Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefoxitin Prophylaxis for Post-ERCP Bacteremia
NCT02958059Unknown
- Sponsor
- Yonsei University
- Start
- Dec 2016
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of cefoxitin in Bacteremia and cholangitis, sponsored by Yonsei University. Primary endpoint: Rate of complication related with infection at 10 days. Status: unknown.
02
Drugs
cefoxitin
03
Conditions
Bacteremiacholangitis
Beyond the preview
Go deeper on NCT02958059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02958059.